Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
Daiichi Sankyo and Merck team up on $22 bln collaboration for Sankyo's antibody drug conjugates
07:46pm, Thursday, 19'th Oct 2023
Daiichi Sankyo and Merck have entered into an agreement worth up to $22 billion for three of Daiichi Sankyo's DXd antibody drug conjugate (ADC) candidates, the companies said on Thursday.
Merck (MRK) Falls More Steeply Than Broader Market: What Investors Need to Know
07:34pm, Thursday, 19'th Oct 2023
In the closing of the recent trading day, Merck (MRK) stood at $100.43, denoting a -1.53% change from the preceding trading day.
Merck (MRK) Reports Next Week: Wall Street Expects Earnings Growth
11:19am, Thursday, 19'th Oct 2023
Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Merck's (MRK) Keytruda Gets FDA Nod in Sixth NSCLC Indication
12:46pm, Tuesday, 17'th Oct 2023
FDA has approved the expanded use of Merck's (MRK) Keytruda in certain patients with early-stage non-small cell lung cancer who can get their tumors removed surgically.
EU regulator backs Merck's viral infection drug
07:06am, Tuesday, 17'th Oct 2023
European health regulator backed Merck & Co's drug to treat a type of infection in adult kidney transplant recipients at high risk, the company said on Tuesday.
Merck's Keytruda gets U.S. FDA's nod for expanded use in lung cancer
06:58pm, Monday, 16'th Oct 2023
The U.S. Food and Drug Administration on Monday approved the expanded use of Merck & Co's blockbuster immunotherapy Keytruda in early-stage patients with non-small cell lung cancer who can get their t
CHMP Endorses Merck's (MRK) Keytruda Expansion in Gastric Cancer
12:02pm, Monday, 16'th Oct 2023
If approved, Merck's (MRK) Keytruda will be approved for a second indication in advanced gastric or GEJ cancer.
Worried About a Recession? This Pharma Stock Could Be the Safe Haven You Need.
03:06am, Monday, 16'th Oct 2023
When you're concerned about an economic downturn, a relatively safe solution is to stick with famous names like Merck (NYSE: MRK ). I recommend holding MRK stock, reinvesting the dividend payments and
Merck to Present Latest Research from Oncology Portfolio at ESMO 2023
02:00am, Monday, 16'th Oct 2023
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research on the company's oncology portfolio addressing unm
7 Safe Stocks to Steady Your Portfolio in 2024
01:30pm, Sunday, 15'th Oct 2023
With the high-flying equities sector suddenly going soft in the second half, investors may want to consider safe stocks. These ideas might not be the first choice among market participants.
Why the Market Dipped But (MRK) Gained Today
06:47pm, Friday, 13'th Oct 2023
Merck (MRK) closed at $104.01 in the latest trading session, marking a +0.41% move from the prior day.
(MRK) Rises As Market Takes a Dip: Key Facts
07:33pm, Thursday, 12'th Oct 2023
In the latest trading session, Merck (MRK) closed at $103.59, marking a +0.13% move from the previous day.
Merck immunotherapy shows further promise in lung cancer
09:11am, Tuesday, 10'th Oct 2023
Merck & Co confirmed that its cancer drug Keytruda has successfully met the second of its two primary targets in a phase III clinical trial, showing significant improvement as a treatment administ
Merck reports positive results for blockbuster cancer drug in treating non-small cell lung cancer
06:56am, Tuesday, 10'th Oct 2023
Merck & Co. said Tuesday a late-stage trial of its blockbuster cancer drug Keytruda as a treatment for several types of non-small cell lung cancer, or NSCLC, met its primary endpoint of overall surviv
Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
06:47pm, Friday, 06'th Oct 2023
The latest trading day saw Merck (MRK) settling at $103.88, representing a +0.27% change from its previous close.
